ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001468223

MVA Investors, LLC

CIK 0001468223 Name as filed on the most recent filing

Filed as MVA Investors, LLC (26)

66 transaction lines · from 26 filings · filed 2013-08-20 to 2024-07-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2024-07-02 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 95,000 disposed 8.68 824,600.00 Form 4, filing 0000895345-24-000245
2024-07-01 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 110,731 disposed 8.87 982,183.97 Form 4, filing 0000895345-24-000245
2024-06-28 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 29,000 disposed 8.57 248,530.00 Form 4, filing 0000895345-24-000245
2024-06-07 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 77,000 disposed 6.88 529,760.00 Form 4, filing 0000895345-24-000225
2024-06-06 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 63,000 disposed 7.24 456,120.00 Form 4, filing 0000895345-24-000225
2024-05-03 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 60,000 disposed 7.61 456,600.00 Form 4, filing 0000895345-24-000151
2024-05-02 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 75,000 disposed 7.56 567,000.00 Form 4, filing 0000895345-24-000151
2024-05-01 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 75,000 disposed 7.43 557,250.00 Form 4, filing 0000895345-24-000151
2023-10-16 Tango Therapeutics, Inc.
TNGX 		P, Open-market purchase 500,000 acquired 6.84 3,420,000.00 Form 4, filing 0000895345-23-000589
2023-10-16 Tango Therapeutics, Inc.
TNGX 		P, Open-market purchase 500,000 acquired 6.84 3,420,000.00 Form 4, filing 0000895345-23-000588
2023-10-13 Tango Therapeutics, Inc.
TNGX 		P, Open-market purchase 750,000 acquired 7.07 5,302,500.00 Form 4, filing 0000895345-23-000589
2023-10-13 Tango Therapeutics, Inc.
TNGX 		P, Open-market purchase 750,000 acquired 7.07 5,302,500.00 Form 4, filing 0000895345-23-000588
2023-10-09 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 175,000 disposed 9.97 1,744,750.00 Form 4, filing 0000895345-23-000574
2023-10-09 Tango Therapeutics, Inc.
TNGX 		S, Open-market sale 50,000 disposed 9.91 495,500.00 Form 4, filing 0000895345-23-000574
2023-08-11 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 1,201,440 acquired 27.80 33,400,032.00 Form 4, filing 0000895345-23-000499
2023-08-11 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 57,533 acquired 27.80 1,599,417.40 Form 4, filing 0000895345-23-000499
2023-08-11 Tango Therapeutics, Inc.
TNGX 		P, Open-market purchase 475,000 acquired 5.15 2,446,250.00 Form 4, filing 0000895345-23-000498
2023-08-11 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 1,201,440 acquired 27.80 33,400,032.00 Form 4, filing 0000895345-23-000500
2023-08-11 Mirati Therapeutics, Inc.
MRTX 		P, Open-market purchase 57,533 acquired 27.80 1,599,417.40 Form 4, filing 0000895345-23-000500
2023-02-10 Tyra Biosciences, Inc.
TYRA 		S, Open-market sale 65,568 disposed 13.40 878,611.20 Form 4, filing 0000895345-23-000107
2023-02-09 Tyra Biosciences, Inc.
TYRA 		S, Open-market sale 200,000 disposed 13.10 2,620,000.00 Form 4, filing 0000895345-23-000107
2022-10-13 Tango Therapeutics, Inc.
TNGX 		P, Open-market purchase 70,000 acquired 4.65 325,227.00 Form 4, filing 0000899243-22-033595
2022-10-12 Tango Therapeutics, Inc.
TNGX 		P, Open-market purchase 50,000 acquired 4.43 221,640.00 Form 4, filing 0000899243-22-033595
2022-10-11 Tango Therapeutics, Inc.
TNGX 		P, Open-market purchase 117,000 acquired 4.25 497,706.30 Form 4, filing 0000899243-22-033595
2022-01-04 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 88,054 disposed 41.84 3,684,355.47 Form 4, filing 0000899243-22-001072
2022-01-04 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 33,297 disposed 44.44 1,479,771.96 Form 4, filing 0000899243-22-001072
2022-01-04 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 29,623 disposed 41.84 1,239,485.57 Form 4, filing 0000899243-22-001072
2022-01-04 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 11,199 disposed 44.44 497,701.48 Form 4, filing 0000899243-22-001072
2022-01-04 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 9,366 disposed 43.36 406,109.76 Form 4, filing 0000899243-22-001072
2022-01-04 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 7,483 disposed 45.48 340,309.63 Form 4, filing 0000899243-22-001072
2022-01-04 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 3,138 disposed 43.36 136,062.42 Form 4, filing 0000899243-22-001072
2022-01-04 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 2,517 disposed 45.48 114,467.37 Form 4, filing 0000899243-22-001072
2022-01-03 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 432,903 disposed 47.65 20,626,182.92 Form 4, filing 0000899243-22-001072
2022-01-03 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 39,481 disposed 49.37 1,949,354.63 Form 4, filing 0000899243-22-001072
2022-01-03 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 23,353 disposed 47.63 1,112,245.01 Form 4, filing 0000899243-22-001072
2022-01-03 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 17,173 disposed 50.63 869,534.25 Form 4, filing 0000899243-22-001072
2022-01-03 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 1,682 disposed 49.37 83,048.58 Form 4, filing 0000899243-22-001072
2022-01-03 iTeos Therapeutics, Inc.
ITOS 		S, Open-market sale 731 disposed 50.63 37,013.31 Form 4, filing 0000899243-22-001072
2021-09-17 Tyra Biosciences, Inc.
TYRA 		P, Open-market purchase 625,000 acquired 16.00 10,000,000.00 Form 4, filing 0000899243-21-036419
2021-04-27 Rain Therapeutics Inc.
RAIN 		P, Open-market purchase 1,025,000 acquired 17.00 17,425,000.00 Form 4, filing 0000899243-21-017115
2021-04-23 Rain Therapeutics Inc.
RAIN 		P, Open-market purchase 125,000 acquired 16.27 2,033,750.00 Form 4, filing 0000899243-21-017115
2021-04-23 Rain Therapeutics Inc.
RAIN 		P, Open-market purchase 25,000 acquired 15.58 389,500.00 Form 4, filing 0000899243-21-017115
2021-03-05 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 363,000 disposed 181.15 65,757,450.00 Form 4, filing 0000899243-21-010812
2021-03-05 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 37,000 disposed 181.15 6,702,550.00 Form 4, filing 0000899243-21-010812
2021-03-05 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 4 disposed 181.00 724.00 Form 4, filing 0000899243-21-010812
2021-03-05 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 1 disposed 181.00 181.00 Form 4, filing 0000899243-21-010812
2020-10-30 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 362,950 disposed 202.00 73,315,900.00 Form 4, filing 0000899243-20-030060
2020-10-30 Mirati Therapeutics, Inc.
MRTX 		S, Open-market sale 37,050 disposed 202.00 7,484,100.00 Form 4, filing 0000899243-20-030060
2020-09-25 PMV Pharmaceuticals, Inc.
PMVP 		P, Open-market purchase 950,000 acquired 18.00 17,100,000.00 Form 4, filing 0001209191-20-052341
2020-07-28 iTeos Therapeutics, Inc.
ITOS 		P, Open-market purchase 1,401,448 acquired 19.00 26,627,512.00 Form 4, filing 0000899243-20-020687

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. MVA Investors, LLC, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001468223

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.